LHs post says similar things to what I say but just a different...

LHs post says similar things to what I say but just a different way.

The value of this company should be double or triple the current level (IMHO) but all those who know and care about it have already bought. When good news comes out there is often a responsive take profit reaction which disheartens the fresh interest and fizzles the SP.

I think LH is basically saying the same thing as me except I actually think RH has done a great job explaining (when he does) but the audience is very limited. He should ramp up the whole IR channels (especially offshore ie broker/investor roadshow instead of the science conferences) in the next 6 months BEFORE he drops a few bombshells out there or it will fall on the same investors ears and we will remain undervalued.

I fear if he doesn't do this then his best value will be assessed as back in the lab and we already have a CSO. The 2 of them are in the right roles respectively but the CEO role has a larger strategy/business development/ investor relations hat than we are currently experiencing. Right now it feels like they could drop stellar results from the animal studies and the world misses it! I can't help but feel like all the value in the stock is going to be realized right at the last minute . . .